| 查看: 191 | 回复: 0 | |||
| 当前主题已经存档。 | |||
lw1966hhh铁杆木虫 (著名写手)
|
[交流]
研究一下路透社对小日本药物市场的分析《Jp Pharm Companies Outlook》
|
||
|
The Japanese Pharmaceutical Companies Outlook: An analysis of key players and growth strategies evaluates the strengths and weaknesses of the top 10 Japanese pharmaceutical firms' strategic and financial positions, marketed portfolios and pipeline compounds. This report will enable you to assess the market dynamics within the Japanese pharma market and understand how companies are positioning themselves at a time of significant change in their domestic market. The Japanese pharmaceutical market is the second largest in the world, behind only the US, with estimated sales of $52bn in 2002. While it makes it an attractive target for Western companies' expansion plans, low market growth (1% in 2002) has made the operating environment increasingly difficult for domestic players. Coupled with ongoing regulatory reforms and drug price cuts, which are largely intended to reduce the government's healthcare bill, Japanese companies are being forced to adapt their operating strategies. http://rapidshare.de/files/28238 ... es_Outlook_2004.pdf |
回复此楼» 猜你喜欢
麻烦各位老师有HT29-MTX这个细胞株吗，有偿购买！
已经有1人回复
-
2026年申博药学专业
已经有1人回复
-
药物学论文润色/翻译怎么收费?
已经有82人回复
-
2026申博
已经有0人回复
-
合成
已经有0人回复
-
氨基酸的酰化反应，求大佬解答
已经有0人回复
-
26年申博——已发SCI6篇
已经有13人回复
-
碱缸的配制
已经有5人回复
-
新！澳门科技大学诚招2026年秋季药剂学/生物材料方向博士研究生（申请-考核制）
已经有9人回复
